Our Company Knows Stem Cells
Everyone in our company, from R&D to management to marketing, has experience with stem cell research.
Meet the team below.
Dr. Gimble received his M.D. and Ph.D. from Yale University, where he began his 30+ year research career. During this time, he has held several full-time and adjunct faculty positions, and has biotechnology industry experience on staff at Zen-Bio and as a co-founder of Artecel Sciences. Dr. Gimble’s professional career has focused on the isolation, characterization, and clinical translation of stromal/stem cells from adipose tissue, bone, and bone marrow, resulting in more than 200 published manuscripts. Together with Dr. Wu, he co-founded LaCell LLC to provide this expertise to the broader academic and biotech research communities.
Dr. Wu received her M.D. from the Norman Bethun Medical University in Changchun, China. After one year of clinical training, Dr. Wu decided to pursue a research pathway, emigrated to the United States, and began working on stromal/stem cells with Dr. Gimble in 1991. Since, Dr. Wu has worked in stromal/stem cell research in and out of academia, and has co-authored over 50 manuscripts with Dr. Gimble. In 2012, she moved to a full-time position as Vice President of Research & Development at LaCell LLC. Dr. Wu plays an integral role in determining LaCell’s commercial and scientific direction.
Dr. Frazier received her Ph.D. from Tulane University School of Medicine, graduating from the Biomedical Sciences Program in 2012. Her dissertation training projects involved the use of cryopreserved adult mesenchymal stem cells derived from adipose tissue for clinical use in tissue reconstruction and regenerative medicine applications. She has held tenure-track faculty positions at Delgado Community College and served as Program Chair in the Chemistry and Chemical Technology Department at Dillard University. Currently, Dr. Frazier is developing ‘fat-on-a-chip’ technology at LaCell.
Dr. Wicks completed her graduate studies at Guelph University in 2007 and her post-doctoral training at the Pennington Biomedical Research Center, Louisiana State University. At Pennington, she worked with Dr. Gimble to treat a murine model of Krabbe’s disease, a neurodegenerative disorder, by transplanting adipose-derived cells intracranially. In 2015, Dr. Wicks joined LaCell LLC to explore commercial scientific opportunities.
Ryan Fishel earned his Bachelor of Science in Engineering degree in Biomedical Engineering from Tulane in 2017. His research focused on inducing adipose-derived stem cells to a pericyte phenotype in microvascular networks. Additionally, Ryan has industry experience in medical device development and commercialization and is a co-founder of the medical device company CMDX Biopsy.
Bruce Bunnell is the Director of the Tulane Center for Stem Cell Research and Regenerative Medicine in the Tulane University School of Medicine. In addition, he holds the Aron Family Regents Distinguished Chair in Gene Therapy. Dr. Bunnell’s research program is focused on both the basic science and translational applications of adult stem cells isolated from the bone marrow and adipose tissue. Dr. Bunnell investigates the use of mesenchymal stem cells isolated from the bone marrow or adipose tissue as a therapeutic intervention for both Multiple Sclerosis (MS) and acute lung injury. He is currently working towards a human clinical trial for the treatment of MS with these cells.
Dr. Eilertsen is an Associate Professor at the prestigious Pennington Biomedical Research Center of Louisiana State University in Baton Rouge, LA. He founded NuPotential in 2004 based on foundational discoveries and over twenty years of cell reprogramming experience. Currently, Dr. Eilertsen is NuPotential’s President and oversees its scientific operations. Prior to NuPotential, Dr. Eilertsen co-founded Infigen, a company recognized as a world leader in cloning technologies.
Dr. Gawronska-Kozak works as Associate Professor at Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland. Her career has focused in the areas of obesity/adipogenesis and skin wound healing/regeneration that synergize interdisciplinary biomedical research program that integrates biology associated with obesity, wound healing and diabetes. She has more than 20 years of experience in the isolation, culture and characterization of primary cultured cells from: adipose tissues, skin, and ear. Dr. Gawronska-Kozak published more than 60 peer reviewed manuscripts, book chapters and reviews.
Dr. Floyd is an Associate Professor and Co-Director of the Botanical and Dietary Supplement Research Center at the Pennington Biomedical Research Center in Baton Rouge, Louisiana. Her research is focused on adipose tissue function in obesity and metabolic disorders with a specific emphasis on the role of the ubiquitin-proteasome system in adipose tissue biology. Dr. Floyd’s research is currently investigating the relationship between adipocyte expansion by hyperplasia or hypertrophy in adipose tissue inflammation and control of adipogenesis by specific ubiquitin ligases.
Forum graduated from Louisiana State University’s E.J. Ourso College of Business in 2016 with a Master in Business Administration and Johns Hopkins University with a degree in Biomedical Engineering in 2009. She has worked on a number of medical device as well as cell & tissue engineering projects. Prior to working at LaCell, she worked closely with the founders at Pennington Biomedical Research Center. Forum helped the founders establish the business platform for LaCell as the first employee of the company. She has also worked as a Consultant for Ernst & Young, primarily engaged with healthcare clients.
She is currently an Operations Manager at Amazon, Inc.
Dr. Curley received his PhD from Tulane University, graduating from the Department of Biomedical Engineering in 2012. Subsequently, he completed a postdoctoral position abroad at the University of Antwerp in Belgium. His background is in tissue engineering and regenerative medicine, with a focus on highly translational projects. In particular, commercial and entrepreneurial applications have always been of the highest interest to Lowry.
Lowry is now the CEO of Axosim LLC.
James Morgan Dixon is currently a MBA candidate from Tulane University taking courses in entrepreneurship, strategic management and finance. Previously, he graduated with a master’s of science in biomedical engineering from Tulane University focusing on material science and regenerative medicine. Prior to that, he graduated from Louisiana State University A&M with a bachelor’s of science in biological engineering establishing an engineering, biological and chemical foundation. James Morgan’s diverse educational background is suited for business development in the emerging biomedical and life science industry.
Morgan is now in the Tulane MBA/JD program.
Stanley Smith graduated in 2016 from Louisiana State University with a Bachelor’s of Science in Biological Engineering. Originally, he was brought in as a summer intern working under the supervision of Dr. Shawna E. Wicks. At LaCell, he served as a Research Associate, assisting on several projects within the company.
Stanley is now pursuing a Masters degree in Kinesiology from Louisiana State University